Patenting Nanomedicine in Europe:: Applying the 'medical methods exception' to emerging technologies

Ana Nordberg

Patenting Nanomedicine in Europe: Applying the 'medical methods exception' to emerging technologies

Ana Nordberg

CIIR - Center for Informations- og innovationsret

Abstract

Patenting Nanomedicine in Europe: Applying the ‘medical methods exception’ to emerging technologies is based on the authors PhD dissertation, defended in March 2014, at the University of Copenhagen. The book debates restrictions on the patentability of medical methods in European Patent Law. The main question addressed is whether it is viable and advisable the reinterpretation, reformulation or replacement of Article 53 (c) EPC – a provision restricting the patenting of medical methods. The subject is approached by reference to emerging technologies, and using nanomedicine innovation as example and point of departure. Nanotechnology inventions blur the lines between patentable subject matter and what may fall under the exception from patentability. It is a good example of how in recent years, emerging technologies have been challenging the patent system and exposing the need for re-thinking the adopted solutions.

Originalsprog	Engelsk

Udgivelsessted	Copenhagen
Forlag	Djøf Forlag
Antal sider	363
ISBN (Trykt)	9788757435856
Status	Udgivet - jan. 2017

Emneord

Det Juridiske Fakultet

Citationsformater

@book{675ca79dc6ac475980879c8a18434d68,

title = "Patenting Nanomedicine in Europe:: Applying the 'medical methods exception' to emerging technologies ",

abstract = "Patenting Nanomedicine in Europe: Applying the {\textquoteleft}medical methods exception{\textquoteright} to emerging technologies is based on the authors PhD dissertation, defended in March 2014, at the University of Copenhagen. The book debates restrictions on the patentability of medical methods in European Patent Law. The main question addressed is whether it is viable and advisable the reinterpretation, reformulation or replacement of Article 53 (c) EPC – a provision restricting the patenting of medical methods. The subject is approached by reference to emerging technologies, and using nanomedicine innovation as example and point of departure. Nanotechnology inventions blur the lines between patentable subject matter and what may fall under the exception from patentability. It is a good example of how in recent years, emerging technologies have been challenging the patent system and exposing the need for re-thinking the adopted solutions.",

keywords = "Faculty of Law, Nanomedicine patents, Patent law, Methods for treatment patents",

author = "Ana Nordberg",

year = "2017",

month = jan,

language = "English",

isbn = "9788757435856 ",

publisher = "Dj{\o}f Forlag",

}

TY - BOOK

T1 - Patenting Nanomedicine in Europe:

T2 - Applying the 'medical methods exception' to emerging technologies

AU - Nordberg, Ana

PY - 2017/1

Y1 - 2017/1

N2 - Patenting Nanomedicine in Europe: Applying the ‘medical methods exception’ to emerging technologies is based on the authors PhD dissertation, defended in March 2014, at the University of Copenhagen. The book debates restrictions on the patentability of medical methods in European Patent Law. The main question addressed is whether it is viable and advisable the reinterpretation, reformulation or replacement of Article 53 (c) EPC – a provision restricting the patenting of medical methods. The subject is approached by reference to emerging technologies, and using nanomedicine innovation as example and point of departure. Nanotechnology inventions blur the lines between patentable subject matter and what may fall under the exception from patentability. It is a good example of how in recent years, emerging technologies have been challenging the patent system and exposing the need for re-thinking the adopted solutions.

AB - Patenting Nanomedicine in Europe: Applying the ‘medical methods exception’ to emerging technologies is based on the authors PhD dissertation, defended in March 2014, at the University of Copenhagen. The book debates restrictions on the patentability of medical methods in European Patent Law. The main question addressed is whether it is viable and advisable the reinterpretation, reformulation or replacement of Article 53 (c) EPC – a provision restricting the patenting of medical methods. The subject is approached by reference to emerging technologies, and using nanomedicine innovation as example and point of departure. Nanotechnology inventions blur the lines between patentable subject matter and what may fall under the exception from patentability. It is a good example of how in recent years, emerging technologies have been challenging the patent system and exposing the need for re-thinking the adopted solutions.

KW - Faculty of Law

KW - Nanomedicine patents

KW - Patent law

KW - Methods for treatment patents

M3 - Book

SN - 9788757435856

BT - Patenting Nanomedicine in Europe:

PB - Djøf Forlag

CY - Copenhagen

ER -

Patenting Nanomedicine in Europe: Applying the 'medical methods exception' to emerging technologies

Abstract

Emneord

Fingeraftryk

Citationsformater